Jump to content

Abraxane shows potential in Phase I/II trial

Support Team

Recommended Posts

The published results of a Phase I/II trial of Abraxane(paclitaxel albumin-bound particles for injectable suspension) in combination with gemcitabine in advanced pancreatic cancer patients has shown that this treatment shows potential for improving outcomes.

This treatment is being investigated further in an an ongoing, international, randomized phase III trial of Abraxane + gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer. The study is recruiting a large sample (842 people) across 152 sites, but unfortunately is not running in the UK.

For more information http://ir.celgene.com/phoenix.zhtml?c=111960&p=irol-newsArticle_print&ID=1614329&highlight=


Link to comment
Share on other sites

  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. By using our forums you agree to our Terms of Use and Privacy Policy.